Whether you are currently taking tirzepatide, considering it, or simply trying to separate fact from fiction, the evidence tells a clear story
People in trials lost an average of 18.7% of their body weight on Wegovy HD 7.2 mg , compared with 15.6% on 2.4 mg and 3.9% with placebo over 72 weeks
Who Should NOT Use BPC-157 Pregnant or breastfeeding women insufficient safety data Active or recent cancer theoretical angiogenesis concern Uncontrolled bleeding disorders Known peptide allergy Uncontrolled severe cardiovascular disease without specialist clearance Drug Interactions Formal interaction data is limited
As noted by Barkte, supranormal GH levels have been associated with [12]: Increased disease risks Reduced life expectancy Acceleration of aging However, Deepankar et al
Elizabeth Walton, co-founder and clinical director of Risas Kids Dental in Phoenix, told The Post